Literature DB >> 18070246

Differential modulation of ethanol-induced sedation and hypnosis by metabotropic glutamate receptor antagonists in C57BL/6J mice.

Amanda C Sharko1, Clyde W Hodge.   

Abstract

BACKGROUND: Emerging evidence implicates metabotropic glutamate receptor (mGluR) function in the neurobiological effects of ethanol. The recent development of subtype specific mGluR antagonists has made it possible to examine the roles of specific mGluRs in biochemical and behavioral responses to ethanol. The purpose of the present study was to determine if mGluRs modulate the acute sedative-hypnotic properties of ethanol in mice.
METHODS: C57BL/6J mice were tested for locomotor activity (sedation) and duration of loss of the righting reflex (hypnosis) following acute systemic administration of ethanol alone or in combination with the mGluR5-selective antagonist, 2-methyl-6-(phenylethynyl)pyridine (MPEP), the mGluR1-selective antagonist, 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt), or the mGluR2/3-selective antagonist (2S)-2-Amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid (LY341495)).
RESULTS: MPEP (10 and 30 mg/kg) significantly enhanced both the sedative and hypnotic effects of ethanol, while LY341495 (10 and 30 mg/kg) significantly reduced the sedative-hypnotic effects of ethanol. CPCCOEt had no effect at any concentration tested. Further loss of righting reflex experiments revealed that LY341495 (30 mg/kg) significantly reduced hypnosis induced by the gamma-aminobutyric acid type A (GABAA) positive modulators, pentobarbital (50 mg/kg) and midazolam (60 mg/kg), and the N-methyl-d-aspartate (NMDA) receptor antagonist, ketamine (150 mg/kg), while MPEP (30 mg/kg) only significantly enhanced the hypnotic properties of ketamine (150 mg/kg).
CONCLUSIONS: These findings suggest that specific subtypes of the metabotropic glutamate receptor differentially modulate the sedative-hypnotic properties of ethanol through separate mechanisms of action, potentially involving GABA(A) and NMDA receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070246      PMCID: PMC2533745          DOI: 10.1111/j.1530-0277.2007.00554.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  51 in total

1.  Chronic ethanol on mRNA levels of IP3R1, IP3 3-kinase and mGluR1 in mouse Purkinje neurons.

Authors:  A Simonyi; J P Zhang; A Y Sun; G Y Sun
Journal:  Neuroreport       Date:  1996-09-02       Impact factor: 1.837

2.  Anesthesia sensitivity in mice that lack the beta3 subunit of the gamma-aminobutyric acid type A receptor.

Authors:  J J Quinlan; G E Homanics; L L Firestone
Journal:  Anesthesiology       Date:  1998-03       Impact factor: 7.892

3.  (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus.

Authors:  A J Doherty; M J Palmer; J M Henley; G L Collingridge; D E Jane
Journal:  Neuropharmacology       Date:  1997-02       Impact factor: 5.250

4.  Acute ethanol alters calcium signals elicited by glutamate receptor agonists and K+ depolarization in cultured cerebellar Purkinje neurons.

Authors:  D L Gruol; K L Parsons; N DiJulio
Journal:  Brain Res       Date:  1997-10-31       Impact factor: 3.252

5.  Role of protein kinase C phosphorylation in rapid desensitization of metabotropic glutamate receptor 5.

Authors:  R W Gereau; S F Heinemann
Journal:  Neuron       Date:  1998-01       Impact factor: 17.173

6.  Effects of ethanol and anesthetics on type 1 and 5 metabotropic glutamate receptors expressed in Xenopus laevis oocytes.

Authors:  K Minami; R W Gereau; M Minami; S F Heinemann; R A Harris
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

7.  Metabotropic glutamate receptor agonists alter neuronal excitability and Ca2+ levels via the phospholipase C transduction pathway in cultured Purkinje neurons.

Authors:  J G Netzeband; K L Parsons; D D Sweeney; D L Gruol
Journal:  J Neurophysiol       Date:  1997-07       Impact factor: 2.714

8.  Opposite effects of GABAA and NMDA receptor antagonists on ethanol-induced behavioral sleep in rats.

Authors:  D B Beleslin; N Djokanović; D Jovanović Mićić; R Samardzić
Journal:  Alcohol       Date:  1997 Mar-Apr       Impact factor: 2.405

9.  Chronic ethanol-induced subtype- and subregion-specific decrease in the mRNA expression of metabotropic glutamate receptors in rat hippocampus.

Authors:  Agnes Simonyi; Michael R Christian; Albert Y Sun; Grace Y Sun
Journal:  Alcohol Clin Exp Res       Date:  2004-09       Impact factor: 3.455

Review 10.  The metabotropic glutamate receptors: structure and functions.

Authors:  J P Pin; R Duvoisin
Journal:  Neuropharmacology       Date:  1995-01       Impact factor: 5.250

View more
  22 in total

Review 1.  Glutamatergic targets for new alcohol medications.

Authors:  Andrew Holmes; Rainer Spanagel; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2013-09-01       Impact factor: 4.530

2.  Metabotropic Glutamate Receptors in Alcohol Use Disorder: Physiology, Plasticity, and Promising Pharmacotherapies.

Authors:  Max E Joffe; Samuel W Centanni; Anel A Jaramillo; Danny G Winder; P Jeffrey Conn
Journal:  ACS Chem Neurosci       Date:  2018-06-08       Impact factor: 4.418

Review 3.  Metabotropic glutamate receptor ligands as potential therapeutics for addiction.

Authors:  M Foster Olive
Journal:  Curr Drug Abuse Rev       Date:  2009-01

Review 4.  Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder.

Authors:  Sunil Goodwani; Hannah Saternos; Fawaz Alasmari; Youssef Sari
Journal:  Neurosci Biobehav Rev       Date:  2017-02-24       Impact factor: 8.989

5.  Sensitivity to isoflurane anesthesia increases in autism spectrum disorder Shank3+/∆c mutant mouse model.

Authors:  Changsheng Li; Michele Schaefer; Christy Gray; Ya Yang; Orion Furmanski; Sufang Liu; Paul Worley; C David Mintz; Feng Tao; Roger A Johns
Journal:  Neurotoxicol Teratol       Date:  2016-11-14       Impact factor: 3.763

6.  Loss of Adenylyl Cyclase Type-5 in the Dorsal Striatum Produces Autistic-Like Behaviors.

Authors:  Hannah Kim; Yunjin Lee; Jin-Young Park; Ji-Eun Kim; Tae-Kyung Kim; Juli Choi; Jung-Eun Lee; Eun-Hwa Lee; Daesoo Kim; Kyoung-Shim Kim; Pyung-Lim Han
Journal:  Mol Neurobiol       Date:  2016-11-23       Impact factor: 5.590

7.  Glyoxalase 1 (GLO1) Inhibition or Genetic Overexpression Does Not Alter Ethanol's Locomotor Effects: Implications for GLO1 as a Therapeutic Target in Alcohol Use Disorders.

Authors:  Amanda M Barkley-Levenson; Frances A Lagarda; Abraham A Palmer
Journal:  Alcohol Clin Exp Res       Date:  2018-04-18       Impact factor: 3.455

8.  Mice lacking adenylyl cyclase type 5 (AC5) show increased ethanol consumption and reduced ethanol sensitivity.

Authors:  Kyoung-Shim Kim; Hannah Kim; In-Sun Baek; Ko-Woon Lee; Pyung-Lim Han
Journal:  Psychopharmacology (Berl)       Date:  2010-12-31       Impact factor: 4.530

Review 9.  How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective.

Authors:  Peter Clapp; Sanjiv V Bhave; Paula L Hoffman
Journal:  Alcohol Res Health       Date:  2008

10.  Single-channel analysis of ethanol enhancement of glycine receptor function.

Authors:  Brian T Welsh; Beth E Goldstein; S John Mihic
Journal:  J Pharmacol Exp Ther       Date:  2009-04-20       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.